trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['destiny,lung02', 'nsclc', 'lung', 'destiny,lung,4', 'sclc']
the #oncoalerttoptweet #esmo22 day 3 tweet dose matters !!! destiny-lung02 trial
same efficacy, less toxicity including pneumonitis in her2 mut #nsclc with 5.4 6.4 dose. should be the standard dose best, 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??